Talk:Nonspecific Orbital Inflammation (Idiopathic Orbital Inflammation, Orbital Inflammatory Syndrome, Orbital Pseudotumor)

Cytokine/protein specific biologic agents:

2017-10-24 15:57:39-08:00 Tue reinstated sections Infliximab and Rituximab whose text was admixed with citations

1. Paridaens D. van den Bosch WA, van der Loos TL, et al. The effect of etanercept on Graves’ ophthalmopathy ...
2. Antoni C, Braun J. Side effects of anti-TNF therapy ...

Also reinstated cut off citation

1. Ohno S, Nakamura S, Hori S, et al. Efficacy, safety, and pharmacokinetics of multiple administration of infliximab in Behcet's disease with refractory uveoretinitis.

Tony.Ching.AAO (talk) 16:01, October 24, 2017 (PDT)

last revisions with Infliximab and Rituximab removal

• http://eyewiki.org/w/index.php?title=Nonspecific_Orbital_Inflammation_(Idiopathic_orbital_inflammation,_Orbital_inflammatory_syndrome,_Orbital_pseudotumor)&oldid=15040#Etanercept
• http://eyewiki.org/w/index.php?title=Nonspecific_Orbital_Inflammation_(Idiopathic_orbital_inflammation,_Orbital_inflammatory_syndrome,_Orbital_pseudotumor)&oldid=15041

Tony.Ching.AAO (talk) 16:08, October 24, 2017 (PDT)